Nutrafol’s latest product ushers the brand into new (hair care) territory. And it’s a terrific option for guys with short ...
The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive ...
Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...
Hims & Hers bought an at-home lab testing company as it branches out into other clinical areas beyond its recent ...
The Super Bowl aired a Hims & Hers commercial that is receiving backlash for its non-FDA approved weight loss drug. This drug ...
U.K.-based ad agency DAIVID said Pfizer had a strong, positive message with its ad and scored high with intense positive emotions. The commercial was also a top performer with spikes in positive ...
Shares of Hims & Hers Health, the telehealth provider that has found a niche in the obesity-drug boom, surged 28% on Thursday ...
Viewers of the Super Bowl may have seen an ad from one of the largest compounders in the United States, Hims & Hers, ...
Hims & Hers hit the bullseye with its Super Bowl ad ... as unapproved versions do not undergo FDA’s review for safety, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results